Glaxosmithkline | Capitaux D'Emprunt



Loan Capital Changement Date
AbbVie USD 60.34B 1.83B 2024-12
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 21.23B 2.29B 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Indivior 311M 4M 2025-03
J&J USD 38.36B 7.7B 2025-03
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pacira USD 383.54M 2.35M 2024-12
Perrigo USD 3.58B 730.9M 2024-12
Pfizer USD 57.4B 597M 2024-12
Prestige Brands USD 996.05M 55.67M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda JPY 4.7T 277.59B 2024-12
Teva Pharmaceutical Industries USD 16B 398M 2024-12
Zoetis USD 5.22B 1.35B 2024-12



Glaxosmithkline Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.